Amgen Inc. buy Piper Sandler
Start price
10.02.25
/
50%
€288.50
Target price
10.02.26
€318.67
Performance (%)
-10.72%
Price
22.08.25
€250.55
Summary
This prediction is currently active. The price of Amgen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.72%. Dividends of €7.03 are taken into consideration when calculating the performance. This prediction currently runs until 10.02.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.144% | -1.144% |
| iShares Core DAX® | -0.099% | 1.027% |
| iShares Nasdaq 100 | -1.085% | 2.134% |
| iShares Nikkei 225® | -0.835% | 8.556% |
| iShares S&P 500 | 0.099% | 2.881% |
Comments by Piper_Sandler for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Piper Sandler from $310.00 to $329.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat